Google
×
AllImagesVideosNews Maps Shopping Books
Search tools
Past week
  • Recent
  • Past hour
  • Past 24 hours
  • Past week
  • Past month
  • Past year
  • Archives
Sorted by relevance
Clear

Coverage of Dental Services in Traditional Medicare

KFF
In Medicare Physician Fee Schedule Final Rules from recent years, the administration made changes to Medicare payment policies for certain dental services,...
5 days ago

Outcomes with loncastuximab tesirine following CAR T-cell therapy in patients with relapsed or refractory diffuse large B-cell lymphoma

Nature
The efficacy of loncastuximab tesirine (lonca) following chimeric antigen receptor T-cell therapy (CAR-T) progression/failure is unknown.
3 days ago

Chimeric Antigen Receptor (CAR) T-cell Therapy Now Available at LVHN

Lehigh Valley Health Network
Breakthrough immunotherapy activates the immune system to selectively recognize and destroy certain cancers.
6 days ago

Health Canada Approves Cilta-Cel for Relapsed/Lenalidomide-Refractory Myeloma

OncLive
Health Canada has approved cilta-cel for use in patients with relapsed/lenalidomide-refractory multiple myeloma following 1 to 3 prior lines of therapy.
5 days ago

Carl T. Hayden Veterans' Administration Medical Center | VA Phoenix health care | Veterans Affairs

VA.gov Home | Veterans Affairs
Get address and hours, parking and transportation information, and health services offered at Carl T. Hayden Veterans' Administration Medical Center.
6 days ago

BCMA CAR-T therapy combined with pomalidomide is a safe and effective treatment for relapsed/refractory multiple myeloma

Journal of Translational Medicine
B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor T-cell (CAR T-cell) therapy has exhibited remarkable efficacy in refractory or relapsed...
1 day ago

Ablation Plus Intra-tumoral Therapy May Enhance Immune Responses in Tumors

Cancer Network
Performing ablation and injecting tumor sites with immunotherapy may be “synergistic”, according to Jason R. Williams, MD, DABR.
3 days ago

Maintenance of Patient-Reported Health-Related Quality of Life Post Neoadjuvant Relugolix Prior to the Initiation of Prostate Radiation Therapy

Frontiers
Studies have demonstrated that injectable GnRH receptor agonists further suppress cancer progression when paired with radiotherapy (RT) in patients with...
3 days ago

Immix Biopharma Presents Positive NXC-201 Clinical Data at

GlobeNewswire
75% (12/16) complete response rate observed in relapsed/refractory AL Amyloidosis patients with median 4 prior lines of therapy Data will be presented...
6 days ago

'Immense trauma and harm:' In lawsuit, camper alleges range of abuses at WNC therapy camp

The Asheville Citizen Times
The parents of a former camper who attended Trails Carolina, a now-shuttered Western North Carolina therapy camp, have filed a class action lawsuit,...
6 days ago